SANAA PEER: Open Payments
NPI 1639507932 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 11 payments from 5 companies in 2025. Trend: 2023 $285 · 2024 $227 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 3 | $136 |
| GENZYME CORPORATION | 3 | $99 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $50 |
| Advanced Bionics, LLC | 2 | $38 |
| Genentech USA, Inc. | 1 | $27 |
Products named: Xhance, DUPIXENT, NEFFY, HIRES ULTRA CI HIFOCUS MS ELECTRODE, Xolair.
Industry payments across TX — which companies pay providers there.
